Sign up now!
Don't show this again
Sweepstakes Rules

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
REPORTSCollect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Sponsored by Zoetis

Sponsored By Zoetis


Foregoing CAV breeder vaccination based on ELISA results can backfire

Not vaccinating broiler breeders for chicken anemia virus (CAV) because ELISA results show detectable antibodies could be asking for trouble, says Guillermo Zavala, DVM, PhD, Avian Health International, LLC.

In these situations, he explains, poultry companies wrongly assume birds are protected and there is no need to invest in CAV vaccines, which tend to be expensive.

“But it’s not a good strategy,” he told Poultry Health Today.

Without vaccination, breeders may not have enough CAV antibodies to protect offspring during the first critical 2 weeks of life when chicks are very susceptible to clinical infection.

“What you’re hoping to do with vaccination is to get everybody infected at the same time with the vaccine virus and to raise those titers of antibodies as high as possible and as uniformly as possible.”

Consequences in broilers

When broilers aren’t adequately protected against CAV, the consequences typically show up between 7 and 14 days of age. They’ll have increased mortality and unexplained hemorrhages. They start bleeding on the tips of the wings, he continued during an interview at the 2018 International Poultry Scientific Forum.

Most worrisome is CAV’s impact on the immune system. The virus specifically affects bone marrow cells and stem cells in bone marrow produce T-cells. There are several diseases that depend heavily on T-cell immunity and they include coccidiosis, infectious laryngotracheitis and fowl pox virus.

“If chicken anemia wipes out those bone marrow cells, then you have no way to defend…no matter what, against those diseases…Therefore CAV, or chicken infectious anemia, is very central for the protection of the entire immune system,” Zavala explained.

Rely ‘heavily’ on breeder vaccination

The importance of good immunity is especially important now that at least 40% of the poultry industry is raising flocks without antibiotics and the rest of the industry is reducing antibiotic use.

“There are only a handful of infectious diseases that we should be very concerned about when it comes to immune suppression. CAV is one of them. The second one is Marek’s disease. And the third one is infectious bursal disease. And we do have very good tools, in the form of vaccines, to prevent clinical infection with those viruses. So again, now more than ever, we should concentrate on protecting the immune system,” he said.

Zavala said CAV is extremely difficult to eliminate or even reduce through cleaning and disinfection.

“It’s not realistic to think that by cleaning, disinfection and biosecurity you’re going to really eliminate the problem. The strategy has to be a combination of reducing the numbers or concentration of the virus in the environment through cleaning and disinfection but relying very, very heavily on vaccination of breeding stock,” he said.

Vaccination of breeders against CAV generally takes place at about 10 to 12 weeks of age and some poultry producers vaccinate twice. CAV vaccines are usually administered in drinking water or by injection, Zavala said.


Posted on April 19, 2018

tags: , , ,
  • Salmonella serotypes are changing — monitor which ones are in your flock

    It’s imperative for poultry producers and companies to know what strains of Salmonella may be circulating in their flocks, said Chuck Hofacre, president of the Southern Poultry Research Group in Georgia.

  • Recombinant vaccines for poultry: How to maximize results

    Proper vaccine handling, dosage and administration are key to ensuring thorough and effective coverage. That statement is particularly true when talking about recombinant-vector vaccines.

  • ILT vaccine choices: A closer look

    With continued wild-type ILT challenges in the field, we are faced with a choice of two vaccine options with proven results — with different priorities affecting the final decision.

  • ‘Competitive exclusion’ is potential benefit of live Salmonella vaccines in young birds

    Live vaccines for Salmonella have been found to start offering protection within a few days of administration, acting “almost as a [form of] competitive exclusion,” said Chuck Hofacre, president of the Southern Poultry Research Group.

You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.